InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.050
+0.030 (2.94%)
At close: Apr 1, 2025, 4:00 PM
1.020
-0.030 (-2.86%)
After-hours: Apr 1, 2025, 4:15 PM EDT
InflaRx Employees
InflaRx had 74 employees as of December 31, 2024. The number of employees increased by 12 or 18.97% compared to the previous year.
Employees
74
Change (1Y)
12
Growth (1Y)
18.97%
Revenue / Employee
$2,319
Profits / Employee
-$644,468
Market Cap
70.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IFRX News
- 12 days ago - InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones - GlobeNewsWire
- 25 days ago - InflaRx Showcases Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting - GlobeNewsWire
- 4 weeks ago - InflaRx to Showcase Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting - GlobeNewsWire
- 5 weeks ago - InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences - GlobeNewsWire
- 5 weeks ago - InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 6 weeks ago - InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 6 weeks ago - InflaRx Announces Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - InflaRx Announces Participation in Guggenheim SMID Cap Biotech Conference - GlobeNewsWire